RECURSION PHARMACEUTICALS, INC.RXRX
| Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Cash and cash equivalents | 285 | 550 | 392 |
---|
Restricted cash | 2 | 1 | 3 |
---|
Accounts receivable | 0 | - | - |
---|
Other receivables | 9 | 3 | 3 |
---|
Other receivables | 9 | 3 | 3 |
---|
Other current assets | 8 | 16 | 40 |
---|
Investments | 231 | - | - |
---|
Total current assets | 535 | 570 | 438 |
---|
Other current assets | 8 | 16 | 40 |
---|
Total current assets | 535 | 570 | 438 |
---|
Restricted Cash, Noncurrent | 9 | 8 | 7 |
---|
Property and equipment, net | 65 | 88 | 87 |
---|
Operating lease right-of-use assets | - | 33 | 34 |
---|
Intangible assets, net | 1 | 1 | 36 |
---|
Goodwill | 1 | 1 | 52 |
---|
Other Assets, Noncurrent | 0 | - | 0 |
---|
Total assets | 610 | 701 | 654 |
---|
Accounts payable | 3 | 5 | 4 |
---|
Accrued Liabilities, Current | 32 | 33 | 47 |
---|
Unearned revenue | 10 | 57 | 36 |
---|
Notes payable | 0 | 0 | 0 |
---|
Operating lease liabilities | - | 6 | 6 |
---|
Total current liabilities | 47 | 100 | 93 |
---|
Total current liabilities | 47 | 100 | 93 |
---|
Deferred rent | 4 | - | - |
---|
Unearned revenue, non-current | 7 | 70 | 51 |
---|
Unearned revenue, non-current | 7 | 70 | 51 |
---|
Notes Payable, Noncurrent | 1 | 1 | 1 |
---|
Notes Payable, Noncurrent | 1 | 1 | 1 |
---|
Operating Lease, Liability, Noncurrent | - | 44 | 43 |
---|
Operating Lease, Liability, Noncurrent | - | 44 | 43 |
---|
Deferred tax liabilities | - | - | 1 |
---|
Lease Incentive, Payable, Noncurrent | 9 | - | - |
---|
Total liabilities | 67 | 215 | 190 |
---|
Total liabilities | 67 | 215 | 190 |
---|
Common Stock, Value, Issued | 0 | 0 | 0 |
---|
Additional paid-in capital | 943 | 1,125 | 1,431 |
---|
Accumulated deficit | -400 | -640 | -968 |
---|
Accumulated other comprehensive loss | -0 | - | - |
---|
Total stockholders’ equity | 543 | 486 | 463 |
---|
Total stockholders’ equity | 543 | 486 | 463 |
---|
Common Stock, Value, Issued | 0 | 0 | 0 |
---|
Additional paid-in capital | 943 | 1,125 | 1,431 |
---|
Accumulated deficit | -400 | -640 | -968 |
---|
Accumulated other comprehensive loss | -0 | - | - |
---|
Total stockholders’ equity | 543 | 486 | 463 |
---|
Total stockholders’ equity | 543 | 486 | 463 |
---|
Total liabilities and stockholders’ equity | 610 | 701 | 654 |
---|
Total liabilities and stockholders’ equity | 610 | 701 | 654 |
---|